SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eye Laser Industry - VISX and Summit BEAM Info

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
To: Peter Granic who wrote ()4/16/1997 9:06:00 PM
From: ren moore   of 178
 
Wednesday April 16 4:15 PM EDT

VISX, Incorporated announces financial results

SANTA CLARA, Calif.--(BUSINESS WIRE)--April 16, 1997--VISX, Incorporated (NASDAQ NM: VISX) today announced financial
results for the first quarter ended March 31, 1997.

Revenues for the first quarter of 1997 were $15,743,000 compared to $11,556,000 for the comparable period of 1996. Net income for the first
quarter of 1997 was $2,699,000, or $0.17 per share, compared to net income of $1,278,000, or $0.08 per share, for the comparable period of
1996.

VISX is a worldwide leader in the development of refractive laser technology. VISX systems are commercially available in the United States
and markets worldwide.

VISX, Incorporated
Condensed Consolidated Statement of Operations
(in thousands, except per share amounts)

(Unaudited)
Three Months Ended
3/31/97 3/31/96

System sales 10,097 9,479
Royalties, service and other revenue 5,646 2,077

Total revenues 15,743 11,556

Cost of revenues 6,464 5,772
Marketing, general and administrative 5,315 3,563
Research, development and regulatory 2,112 1,860

Total costs and expenses 13,891 11,195

Income (loss) from operations 1,852 361

Interest and other income, net 1,215 917

Income (loss) before income taxes 3,067 1,278

Provision for income taxes 368 --

Net income (loss) 2,699 1,278

Net income (loss) per share $0.17 $0.08

Weighted average number of shares
and equivalents outstanding 15,810 16,032


VISX, Incorporated
Condensed Consolidated Balance Sheet
(in thousands)
Unaudited
3/31/97 12/31/96

Cash, cash equivalents and short-term
investments 84,657 88,990
Accounts receivable 23,765 17,904
Inventories 5,303 5,848
Prepaid expenses 679 553

Current assets 114,404 113,295

Property and equipment, net 4,035 3,621
Other assets 2,742 2,773

Total assets 121,181 119,689

Accounts payable 2,717 2,385
Accrued liabilities 17,441 18,032

Current liabilities 20,158 20,417

Stockholders' equity 101,023 99,272

Total liabilities and stockholders'
equity 121,181 119,689

CONTACT: VISX, Incorporated
Lola Wood, 408/733-2020
Jeffrey Volk, 212/838-3777
E-Mail: ir@visx.com
Web: visx.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext